Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial

Table 2 WOMAC scores at M3 in patients receiving Phytalgic^® and those receiving placebo

	Phytalgic^® n = 41	Placebo n = 40	Difference Phytalgic^® - Placebo	P
Pain
Mean (± std)	86.5 ± 94.3	235.3 ± 136.2	-148.8 ± 26.1	<0.001
[95% CI]	[56.2; 116.9]	[194.2; 276.5]	[-97.7; -199.9]
Stiffness
Mean (± std)	41.4 ± 49.7	96.3 ± 71.0	-54.9 ± 13.8	<0.001
[95% CI]	[25.6; 57.2]	[74.5; 118.2]	[-27.9; -81.9]
Function*
Mean (± std)	301.6 ± 315.6	746.5 ± 462.8	-444.8 ± 89.6	<0.001
[95% CI]	[200.1; 403.1]	[603.1; 890.0]	[-269.1; -620.4]
Total*
Mean (± std)	430.1 ± 448.6	1085.4 ± 654.1	-655.2 ± 127.5	<0.001
[95% CI]	[285.0; 575.1]	[882.0; 1288.9]	[-405.4; -905.1]

*four patients with missing scores at baseline, M1, M2 and M3 (two patients in each group).

ISSN: 1478-6362